Skip to main content

MARSHALL WACE, LLP

Position in APLS — Apellis Pharmaceuticals, Inc.

CIK 1318757 LONDON, X0

Position in APLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
929,019
-6.2% QoQ
Ownership
0.726%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in APLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in APLS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-03-31 929,019
2025-12-31 990,848
2025-09-30 396,735
2025-06-30 2,704,837
2025-03-31 23,574
2024-12-31 85,495
2024-09-30 21,790
2024-03-31 171,873
2023-12-31 230,876
2023-09-30 169,294
2023-06-30 342,352
2023-03-31 92,446
2022-12-31 436,423
2022-09-30 336,727
2022-06-30 1,368,407
2022-03-31 915,163
2021-06-30 10,375